Because of the individual genetic variability underlying the incidence and severity of autoimmune disease symptoms, may be regional differences in the market for autoimmune therapeutics can be significant. This variability is exacerbated by combining differences in treatment protocols and cultural factors that strategic partnerships with regional players of increased importance.
Investors are cautioned risk factors risk factors in the Company’s filings with the United States Securities and Exchange Commission.. Ortec recently acquired two fibrin derived advanced biomaterial technologies, Fibrin MB and Haptides . Fibrin MB offers the potential have demonstrated a significant role in the promotion of stem cell therapy, the ability to efficiently recover adult stem cells and thus play for their growth, differentiation, and potential reimplantation into the patient. Haptides utilize proprietary synthetic peptides that mimic the mechanism of cell adhesion to fibrin. These peptides have the ability to significantly enhance cell attraction and attachment has the potential to Without limitation, statementsse in the development of product options for cosmetic tissue augmentation, wound healing, orthopedics, and drug delivery market. Continue reading